Man-beta1-6-Ins-1-P-Cer(d20:0/2-OH-26:0)

Term ID

CHEBI:60419

Synonyms

(2S,3R)-3-hydroxy-2-[(2-hydroxyhexacosanoyl)amino]icosyl (1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-(D-mannopyranosyloxy)cyclohexyl hydrogen phosphate
1D-6-O-(D-mannopyranosyl)-myo-inositol 1-{(2S,3R)-3-hydroxy-2-[(2-hydroxyhexacosanoyl)amino]icosyl hydrogen phosphate}
mannosylinositol phosphorylceramide B' (20:0/26:0)
mannosylinositol phosphorylceramide B' (C26)
MIPC-2' (C26)
MIPC-B' (C26)

Definition

A mannosylated ceramide phosphoinositol compound having a hexacosanoyl group attached to the ceramide nitrogen, with hydroxylation at C-2 of the very-long-chain fatty acid.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: Man-1-6-Ins-1-P-Cer(d20:0)

Man-1-6-Ins-1-P-Cer(d20:0) Show first 5 Terms
has_functional_parent: Ins-1-P-Cer(d18:0/2-OH-26:0)

Ins-1-P-Cer(d18:0/2-OH-26:0) Show first 5 Terms
inverse has_functional_parent: Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(d20:0/2-OH-26:0)

Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(d20:0/2-OH-26:0) Show first 5 Terms

Phenotype

Phenotype resulting from Man-beta1-6-Ins-1-P-Cer(d20:0/2-OH-26:0)

Phenotype where environments contain Man-beta1-6-Ins-1-P-Cer(d20:0/2-OH-26:0)

Phenotype modified by environments containing Man-beta1-6-Ins-1-P-Cer(d20:0/2-OH-26:0)

Human Disease Model